APA (7th ed.) Citation

Deng, W., Xie, J., Wang, T., Luo, L., Zhu, G., Xiao, Y., . . . Shan, R. (2025). The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinoma. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14185-x

Chicago Style (17th ed.) Citation

Deng, Wei, et al. "The Safety and Efficacy of Tyrosine Kinase Inhibitors and Programmed Cell Death Protein- 1 Inhibitors Combined with HAIC/TACE in the Treatment of Recurrent Unresectable Hepatocellular Carcinoma." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14185-x.

MLA (9th ed.) Citation

Deng, Wei, et al. "The Safety and Efficacy of Tyrosine Kinase Inhibitors and Programmed Cell Death Protein- 1 Inhibitors Combined with HAIC/TACE in the Treatment of Recurrent Unresectable Hepatocellular Carcinoma." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14185-x.